MedTrace Logo

Trial of Vitamin D3 Supplementation in Paediatric Autism

NCT02508922 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2016-10-25

No results posted yet for this study

Summary

To build on a recent case study and open label trial, the investigators want to find out if vitamin D supplementation can influence behavioural and core symptoms of autism.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

2,000iu vitamin D drops will be taken daily for 20 weeks

DIETARY_SUPPLEMENT

Placebo

Matching placebo drops will be taken daily for 20 weeks

Sponsors & Collaborators

  • The National Children's Hospital, Tallaght

    collaborator OTHER

  • University of Dublin, Trinity College

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-06-30
Completion
2016-07-31

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02508922 on ClinicalTrials.gov